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Inhibition of white blood cell adhesion at 
reperfusion decreases tissue damage in 
postischemic striated muscle 
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Purpose: To determine the impact of white blood cell (WBC)-endothelium adhesion on 
tissue damage in the setting of ischemia-reperfusion injury in striated musde. 
Methods: The cremaster muscle of four groups of anesthetized Sprague-Dawley rats was 
subjected to 4 hours of global, warm (37 ° C) ischemia nd 2 hours of reperfusion. At 
reperfusion two groups of animals received intravenous injections of monoclonal 
antibodies directed against either CD11b/CD18 (1B6) or ICAM-1 (1A29). The 
remaining two groups of animals received saline injections (NoR.,) or nonreactive IgG i. In 
vivo light microscopic techniqueS were used to determine WBC adherence (number of 
WBCs per 100 gm postcapillary venules) at different intervals of reperfusion. Muscle 
viability was assessed with computer-assisted image analysis by measuring the optical 
intensity of transilluminated muscles after incubation with nitroblue tetrazolium. 
Results: Out results (mean + SEM) demonstrate a significant increase in the number of 
adherent WBCs relative to baseline (8.0 + 0.5) after 4 hours of global ischemia in animals 
receiving NoR~ or IgG 1. The significant increase occurred at 30 minutes of reperfusion 
(17.6 + 0.6 and 17.4 + 0.4 for NoR~ or IgG1, respectively) and was sustained for the 
duration of the experiment. This increase in adherence was attenuated by 1B6 and 1A29 
(12.2 + 2.2 and 12.4 + 0.8, respectively; p < 0.05 compared with Nol~ and IgG1). The 
decrease in WBC adhesion was associated with a decrease in reperfusion injury to the 
muscle, as indicated by lower optical intensity values for the 1B6 and 1A29 groups 
(123 + 3 and 129 + 2) compared with the NoR~ and IgG 1 groups (151 + 2 and 158 + 4). 
Conclusions: Our data support an important role for WBCs in the pathogenesis of 
ischemia-reperfusion injury. Interfering with e WBC-endothelium interactions by using 
monoclonal ntibodies directed against WBCs and endothelial cell adhesion molecules may 
help to limit ischemia-reperfusion injury. (J Vasc Surg 1996;24:187-93.) 
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Ischemia-reperfusion (I-R) injury in skeletal 
muscle is a paradoxical and complex mulufactorial 
process. With the reintroduction ofmolecular oxygen 
to tissues subjected to an ischemic insult, oxygen- 
derived free radicals are formed, circulating white 
blood cells (WBCs) accumulate, and platelet-activat- 
ing factor and other proinflammatory agents are 
produced. These mediators, once present in this 
environment, combine through an intricate series of 
incompletely understood interactions, and result in 
reperfusion injury. This injury manifests as endothe- 
lial cell dysfuncuon and parenchymal cell damage. 
The important contributions of oxygen-derived free 
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radicals, WBCs, and platelet-activating factor to en- 
dothelial cell dysfunction have been described. 1-6 
However, the cause-effect relationship of circulating 
WBCs to skeletal muscle cell damage that results from 
I-R injury has been less intensely investigated and 
remains poorly defined. 
In one study that was designed to address this 
question, Belkin et al., s used whole-body irradiation 
of rats to achieve leukopenia nd were able to dem- 
onstrate a reduction in parenchymal skeletal muscle 
cell I-R injury. Becanse of the nonspecificity of this 
method for WBC depletion, however, all cell lines 
were diminished. Therefore, the attenuation i I-R 
injury could not be attributed solely to a decrease 
in circulating WBCs. Recently, monoclonal ntibod- 
ies that are highly specific to WBC adhesion mole- 
cules (CD 11/CD 18) and their endothelial ligands 
(ICAM-1) have become available. 7-9 Maldng use of 
these new molecular tools, our experiments were 
designed to characterize specifically the WBC- 
endothelial cell interaction during the reperfusion of 
skeletal muscle and tO assess the impact ofthis interac- 
tion on the severity ofparenchymal ce l damage. 
M_ATERIALS AND METHODS 
Surgical preparation of cremaster muscle. 
Twenty Sprague-Dawley rats weighing between 125 
and 210 g were anesthetized with sodium pentobar- 
bital (45 mg/kg by intraperitoneal injection). The 
animals were placed on a heaung pad maintained at
37 ° C. The trachea was intubated to facilitate venti- 
lation. An external jugular rein was cannulated to 
administer supplementary doses of anesthesia (4 to 
6 mg/kg) and monoclonal nd control antibodies. A 
carotid artery was cannulated to monitor blood 
pressure during the course of the experiment. Animal 
care complied with the "Principles of Laboratory 
Animal Care" (formulated by the National Society for 
Medical Research) and the Guide for the Care and Use 
of Laboratory Animals (NIH Publication No. 86-23, 
revised 1985). 
The cremaster muscle was prepared for intravital 
microscopy according to methods previously re- 
ported) ° Briefly, the animal was placed in the supine 
position on a Lucite board fitted with an elevated, 
transparent stage. Using a scrotal incision, the muscle 
was gently separated from the sldn and cleared of 
connective tissue by blunt dissection. A ligature rhen 
was placed at the most distal aspect of the muscle and 
was used to tent he unopened muscle over the Lucite 
stage. To avoid compromising the muscle's blood 
supply, the cremaster muscle was opened in a longi- 
tudinal fashion with thermocautery. The muscle then 
was splayed across the stage with five to seven circum- 
ferentially placed ligatures. The tension exerted by the 
threads was controlled so that microvascular flow was 
not impaired. The vessels connecting the cremaster 
muscle and epididymis were divided by thermocau- 
tery. The remainder of the mesoepididymis was di- 
vided close to the muscle and, along with the testis, 
was placed in the abdominal cavity. During surgery, 
care was taken to keep the cremaster muscle moist by 
superfusing it with normal saline solution. 
A suffusate chamber then was constructed around 
the muscle by fastening a Lucite O-ring, which 
completely surrounded the muscle, to the elevated 
stage. Compression of the muscle pedicle was pre- 
vented by maldng aslit in the side of the O-ring that 
faced the inguinal origin of the muscle. A silicon 
gasket ring at the O-ring/stage interface prevented 
suffusatc loss. Fluid loss at the junction of the pedicle 
and the O-ring slit was prevented by the creation of a 
temporary gasket with vacuum grease. Finally, to 
ensure proper optical transmission during the bicar- 
bonate buffer superfusion and to insulate the muscle 
from atmospheric oxygen, aglass coverslip was placed 
atop a three-sided Mylar nonocclusive support hat 
rested on the periphery of the muscle. 
Throughout the experiment, the cremaster 
muscle was suffused with a bicarbonate buffer solu- 
tion of the following composition: 131.9 mmol/L 
sodium chloride, 4.7 mmol/L potassium chloride, 
2 mmol/L calcium chloride, 1.2 mmol/L magne- 
sium sulphate, and 18 mmol/L sodium hydrochlo- 
ride. The buffer was adjusted to pH 7.4, equilibrated 
with 95% nitrogen and 5% carbon dioxide, and 
maintained at37 ° C. This solution entered and exited 
the muscle chamber through portals 180 ° apart from 
one another in the Lucite O-ring welk 
At the end of the preparatory procedurc, the rat 
and the Lucite board were placed on the microscope 
stage for intravital observation. Intravital micro- 
scopic observations were made with a microscope 
(Microphot, Nikon, MeMlle, N.¥.) equipped for 
bright-field transillumination. The recording system 
consisted of a television camera mounted to the 
microscope and couplcd to a television monitor and a 
videotape recorder. 
Experimental protocols. In all groups, during 
the 1-hour stabilization period, the cremaster muscle 
was suffused with deoxygenated, warm (37 ° C) bi- 
carbonate buffer. At the end of the stabilization 
pcriod, the baselinc number of WBCs adhering to 
postcapillary venules 20 to 40 gm in diameter was 
recorded. The cremaster vascular pedicle then was 
cross-clamped with atraumatic microclips for a period 
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of 4 hours. At the end of the ischemic period, blood 
flow was reinstituted by releasing the clips from the 
cremaster pedicle. In the animal groups receiving 
control or experimental antibodies, the antibody was 
administered intravenously asa 0.1 ml fluid bolus 
injected slowly at reperfusion as the microclips were 
release& Animals that received no antibody were 
given a 0.1 ml fluid bolus of normal saline. The 
number of adhering WBCs then was recorded at 5, 
30, 60, and 120 minutes ofreperfusion. The analysis 
to determine adherence of WBCs was performed by 
videotape playback. WBC adherence was operation- 
ally defined as the number of WBCs that remained 
stationary for 30 or more seconds, over a vessel length 
of 100 btm, in postcapillary venules 20 to 40 btm in 
diameter. 
Muscle viability (tissue damage) was determined 
at the end of the reperfusion period. The excised 
cremaster muscle was incubated in a 0.2% nitroblue 
tetrazolium (NBT)/phosphate-buffered saline solu- 
tion for 45 minutes, and then allowed to dry for 12 
hours at 25 ° C. Tetrazolium salts have been used as 
histochemical markers for detection ofmuscle infarc- 
tion both in cardiac and skeletal muscle} TM NBT is a 
tetrazolium salt that is yellow in solution; when 
incubated with vital tissue it is reduced to a deep blue 
formazan precipitate. The formazan precipitate binds 
to the surface of the exposed muscle) 4 The more 
viable the muscle, the more NBT will be reduced and 
taken up by the muscle, and the darker the muscle will 
turn. Relative muscle viability then was determined by
measuring the optical intensity (OI) of the NBT- 
treated muscles via videomicroscopy coupled to com- 
puter-assisted image analysisJ  More viable musdes 
were darker in color and allowed less light to pass 
through, which resulted in lower OI values. 
Antibodies. Monoclonal antibody (mAb) 1Bö 
(Repligen Corp., Cambridge, Mass.) is directed 
against he CDI lb  c~-subunit of the [~2 Integrin 
CDl l /CD18 WBC adhesion glycoprotein. The 
monoclonal ntibody 1A29, which reacts with the in- 
tercellular adhesion molecule- 1 (ICAM- 1), was de- 
veloped and provided by one of the authors (M.M.). 
The nonreactive isotype IgG 1 (Sigma Chemical Co., 
St. Louis) was used as a control for the mAbs. The 
monoclonal ntibodies 1Bö and IA29, as weil as the 
nonreactive IgG, were administered intravenously at a 
concentration f 2 mg/kg. The specificity of 1Bö to 
react with rat CD1 lb and the specificity of 1A29 to 
react with rat ICAM-1 have been documented 
previously.79 We provide additional in vivo evidence 
of the efficacy of these mAbs to inhibit WBC- 
endothelium adhesion i  this communication. 
Statistical analysis. Data are expressed as the 
mean + standard error of the mean. They were evalu- 
ated initially for differences by analysis of variance 
(ANOVA). The apparent differences then were tested 
for statistical significance by a post-hoc modified 
paired two-tailed Student  test with the Bonferroni 
correction. Differences were considered significant at 
p< 0.05. The statistical analysis package InStat 
(GraphPad Software, Inc., San Diego, Calif.) was 
used in all the experiments. 
RESULTS 
Time course of WBC adhesion. Fig. 1 snmma- 
rizes the data for WBC adhesion kinetics for the 
groups receiving no therapy (NoR.,) and nonreactive 
IgG 1 (IgG). The number of adherent WBCs in- 
creased from a baseline value of 8.0+0.5 to 
17.6 + 0.6, 18.9 + 0.6, and 18.4 + 1.3 at 30, 60, and 
120 minutes in the NoR~ control group. A similar 
time coursc was exhibited by the control animals 
treated with the isotype IgG 1. The increase in the 
number ofadhering WBCs observed at 30 minutes in 
both control groups and sustained for the remainder 
of the observation period was significantly greater 
than baseline value (p < 0.05). 
Fig. 2 displays the data for the groups of animals 
receiving the monoclonal ntibodies 1B6 and 1A29 at 
the time of reperfusion. There was no operational 
significant difference between 1B6 and 1A29 regard- 
ing WBC adhesion to venular endothelium. For the 
group that received mAb 1B6, the number of adher- 
ent WBCs increased from 8.0 + 0.5 at baseline to 
12.2 + 2.2, 13.1 + 2.3, and 13.6 + 0.9 at 30, 60, and 
120 minutes ofreperfusion. 
Comparison of the data in Figs. 1 and 2 demon- 
strates an important and significant difference in the 
number of adhering WBCs between the I-R groups 
and the groups that were treated with mAbs at the 
time ofreperfusion. In the postischemic muscles, the 
mAbs 1B6 and 1A29 significantly reduced the num- 
ber ofadherent WBCs at 30, 60, and 120 minutes of 
reperfusion compared with their respective time- 
matched untreated (NoR,J and IgG 1 control groups 
(p < 0.05). 
Muscle viability (tlssue damage). OI was used as 
an index of viability/tissue damage. Low OI values 
indicate viability and high OI values indicate greater 
tissue damage. The OI values for the experimental 
groups are presented in Fig. 3. The sham group 
(animals undergoing cremasteric dissection, time- 
matched superfusion with bicarbonate buffer, and 
subsequent incubation with NBT) had a mean OI of 
103 + 3, which represents he OI value for muscles 
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Fig. 1. Time-courseofWBCadhesiontoendotheliumofpostcapillaryvenules(PCV)incontrol 
groups. No Rx group was subjected to I-R without herapeutic treatment; IgG group was 
subjected to I-R and received IgG. Data are mean + SEM. *p < 0.05 compared with respective 
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Fig. 2. Time-courseofWBCadhesiontoendotheliumofpostcapillaryvenules(PCV)ingroups 
subjected to I-R and treated at time ofreperfusion with either monoclonal ntibody 1Bö or with 
monoclonal antibody 1A29. Data are mean + SEM. *p < 0.05 compared with respective baseline 
and with measurement at 5 minutes ofreperfusion. 
sustaining injury only from the surgical preparation. 
The NoR~ and IgG experimental postischemic groups 
achieved OI values of 151 + 2 and 158 + 4 units, 
respectively. Postischemic muscles receiving 1Bö and 
1A29 at reperfusion achieved values of 123 + 3 and 
129 + 2 units, respectively. The latter OI values are 
intermediate between those obtained in the sham and 
in the untreated/ IgG 1 postischemic muscles. The OI 
values for the ] B6 and 1A29 groups were significantly 
lower (more viable) than the OI values obtained in 
both the NoR~ and IgG groups (p < 0.01). The four 
experimental groups had OI values that were signifi- 
cantly greater than the sham group (p < 0.05). 
DISCUSSION 
We report two major findings: (1) WBC adher- 
cnce to vcnular endothelium reaches a maximum 
within 30 minutes of institudng reperfusion in stri- 
atcd muscle. This maximal value remains table for at 
least he first 2 hours ofreperfusion. (2) Specific inhi- 
bition ofWBC adherence to endothelium, achieved 
by monoclonal antibodies to either WBC or endothe- 
lium adhesion molecules, ameliorates the extent of 
the injury to striated muscle. Our report tests and 
supports the hypothesis that a cause-effect relation- 
ship exists between WBC-endothelium adhesion and 
parenchymal tissue damage in skeletal muscle. 
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Fig. 3. Index of tissue damage. OI of cremaster muscles pr0cessed for staining with NBT. 
Uptakc of dye is relatcd to musclc viability. The darkcr the musclc, the more viable it is, and the 
lower is its OI. Abscissa Labels: No tL,~, group subjected to I-R without herapeutic treatment; 
IgG, group subjected to I-R and received IgG; 1B6, group subjected to I-R and treated with 
monoclonal ntibody 1B6; 1A29, group subjected to I-R and treated with monoclonal ntibody 
1A29. Data are mean + SEM. *For 1Bö and 1A29 groups, p < 0.05 compared with IgG, No Rx, 
and sham-operated muscles. 
The accumulation ofcirculating WBCs in areas of 
injury and inflammation is the microscopic hallmark 
of acutc inflammatory eactions. In I-R injury, which 
is a special circumstance of the acute inflammatory 
response, circulating WBCs rapidly accumulate in 
postischemic reperfused tissues. A necessary step for 
the recruitmcnt of WBCs to areas of injury is the 
adhesion of  the WBC to vascular endothelial cells. 
WBC-endothelial cell (WBC-EC) adhesion is the 
consequcnce of complex, multicomponent intcrac- 
tions between adhesion moleculcs, which are located 
on the surfaces of these cells. 
Two important adhcsion molcculcs involvcd in 
WBC-EC adhesion are the J3-2 integrin CD 11/CD 18 
complex expressed on the surface of the WBCs and its 
cndothclial-based ligand complex, the intercellular 
adhcsion molcculc-1 (ICAM-1).16 18 The binding of 
CD 11/CD 18 to ICAM- 1 results in the firm adhesion 
of the WBC to the endothelial cell and arrests the 
rolling process mediated by the selcctins. Once CD 18 
engages ICAM-I, firm adhesion ensues, thus en- 
abling the WBC to participate in reperfusion injury. 
This proccss ultimatcly facilitatcs diapcdcsis of the 
WBC across the endothelial wall. 
A rolc for WBCs in I-R injury was initially dem- 
onstratcd in a caninc modcl of myocardial I-R in- 
jury, 19 in which neutrophil depletion with antineutro- 
phil serum reduced infarction in the area of myocar- 
dium at risk. Further evidence for WBC participation 
in reperfusion injury has been provided in several 
studies in skeletal muscle models with a variety of 
techniques to remove circulating WBCs or prevent 
WBC-EC interactions. Using the Leukopak filter 
(Baxter Travenol, Round Lake, Ill.), Korthuis et al. 3 
were able to show that reperfusion of the gracilis 
muscle with WBC-depleted blood significantly ame- 
liorated postischemic increases in vascular permeabil- 
ity and resistance. Similarly, Carden et al., 2° using 
antineutrophil serum and Iß 4 (a monoclonal anti- 
body directed against the [3 subunit of the 
CDl l /CD18 complex), showed reductions in 
ischemia-induced changes in vascular permeability 
and resistance. Breitbart and colleagues, 4 using vin- 
blastine pretreatment to achieve leukopenia in rats, 
reported a marked reduction of the increased mi- 
crovascular t ansport of  macromolecules induced by 
ischemia. Lasfly, Belkin et al., s who achieved leuko- 
penia by whole-body irradiation, demonstrated a 
significant reduction in rat skeletal muscle infarction. 
Although they provide valuable information support- 
ing a role for WBC participation i the pathogenesis 
of I-R injury, several of these studies are subject o 
criticism because of the lack of specificity of the 
methods used to achieve leukopenia. For instance, 
Leukopak filters remove platelets as well as WBCs 
from the circulation. As discussed by Carden et al., 2° 
this caveat must be applied when drawing conclusions 
from these studies because platelets and platelet- 
derived products have also been implicated as media- 
tors in I-R injury. The studies that used chemothera- 
peuUc agents and whole-body irradiation to reduce 
WBC counts also must be interprcted cautiously for 
similar reasons. Furthermore, although these meth- 
ods provide useful laboratory techniques, it would 
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not be acceptable clinically to render patients leuko- 
penic via radiation or chemotherapy in efforts to 
decrease reperfusion i jury. 
In the studies that were discussed previously, all 
treatments and measures that were taken to prevent or 
decrease WBC-rnediated reperfusion i jury were in- 
stituted before the onset of the ischemic insult. A 
therapeutic schedule of this sort would be useful for 
elective surgery. Prophylactic measures, however, 
would not be helpful to physicians and surgeons 
confronted with acutely developing ischemic limbs. 
For these reasons, our study was designed to investi- 
gate the feasibility of administering at reperfusion 
(rather than before ischemia) highly specific mono- 
clonal antibodies to prevent or reduce WBC-EC 
interactions, and to assess the impact ofthis approach 
on the WBC-endothelial cell interaction and the 
degree of skeletal muscle I-R injury. 
Our results clearly show that the administration f 
1B6 and 1A29 at the onset of reperfusion was 
successful in decreasing WBC adherence to the vas- 
cular endothelium. The number of adherent cells, 
however, did not completely return to baseline levels 
during the reperfusion period in either group. This 
may be explained by the fact that 1B6 is specific for 
CD l lb ,  leaving CD11a and CD11c free to interact 
with endothelial dhesion molecules. Other adhesion 
molecules, such as the selectins, are also still free to 
engage endothelial cell surface receptors. Similarly, 
1A29 is specific for ICAM-1. A second, noninducible 
intercellular adhesion molecule (ICAM-2) is present 
on endothelial cells and has been reported to interact 
with CDl la  and CD11b. 21,22 
Out results also demonstrate directly a cause- 
effect relationship between WBC-EC adhesion and 
parenchymal damage. Inhibition of WBC-EC adhe- 
sion significantly ameliorated amage to skeletal 
muscle, as indicated by the OI values hown in Fig. 3. 
The remaining degree of reperfusion i jury that was 
sustained by the groups that received 1B6 and 1A29 
can be explained by several potential mechanisms. 
First, the blockade ofWBC adhesion was partial, so 
that WBCs that did adhere could still migrate and 
contribute to reperfusion i jury. A second potential 
source for non-WBC-mediated injury is oxygen- 
derived free radicals, which have been shown to 
participate in the vascular dysfunction becanse of 
skeletal muscle I-R injury. ~ Third, significant I-R 
injury occurs in the absence of circulating WBCs, as 
reported in an isolated rat hind limb I-R model in 
which the limb was reperfused with a crystalloid 
solution. 23 These results, taken together, emphasize 
the complex, multifactorial nature of I-R injury. 
The results of our experiments demonstrate he 
importance of the WBC-endothelial cell interaction 
in the pathogenesis of I-R injury. Furthermore, our 
study demonstrates thc feasibility of administering 
therapies directed against WBC-EC interactions at 
the onset of reperfusion. Although further experi- 
mental and clinical trials are necessary, this approach 
may prove to be of benefit o vascular surgeons who 
are faced daily with the task ofrestoring blood flow to 
acutely ischemic organs. 
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